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MiceThe aim of our study was to determine the role of corticotropin-releasing factor (CRF), the urocortins
(Ucn1, Ucn2 and Ucn3) and their receptors (CRF1 and CRF2) in the sociability of mice. Male CFLP mice
were administered intracerebroventricularly (icv) with CRF and urocortins alone or in combination with
antalarmin (specific CRF1 antagonist) and astressin2B (specific CRF2 antagonist) and then investigated in a
Crawley social interaction test arena, that consists of three chambers. An unknownmale in a cage was put
in the first chamber and an empty cage was put in the opposite chamber. The tested male was habituated
with the middle chamber for 5 min and then allowed to explore the remaining chambers for 5 min, dur-
ing which the number of entries and the time of interaction were measured. Intracerebroventricular
administration of CRF decreased significantly the number of entries and the time of interaction with
the unknown male and these effects were blocked by antalarmin, but not astressin2B. In contrast, central
administration of Ucn1 increased significantly the number of entries into the chamber of the unknown
male, without changing the time of interaction and this effect was blocked by astressin2B, but not anta-
larmin. Central administration of Ucn2 and Ucn3 didn’t influence remarkably the number of entries, but it
reduced the time of interaction between the male mice. Our study suggests that CRF and Ucn1 may play
important, but different roles in sociability, and that Ucn2 and Ucn3, playing similar roles, must be also
involved in social interactions.
 2017 Elsevier B.V. All rights reserved.1. Introduction
Corticotropin-releasing factor (CRF) is an important neuropep-
tide isolated from the brain that regulates the responses to stress
(Vale et al., 1981). These responses are endocrine, represented by
the activation of the hypothalamic-pituitary-adrenal (HPA) axis
that is reflected by the elevation of concentration of the plasma
adrenocorticotropic hormone (ACTH) and glucocorticoids which
on their turn inhibit the CRF release; autonomic, such as increase
of the blood pressure, increase of the heart rate and vasoconstric-
tion which are mediated by catecholamines released from the
adrenal medulla; metabolic, such as glycogenolysis, gluconeogene-
sis, lipolysis and proteolysis which are mediated by glucocorticoids
released from the adrenal cortex; and behavioral, such as inhibi-
tion of reproduction, increased locomotion in a familiar environ-
ment, decreased locomotion in an unfamiliar environment etc.
(Carrasco and Van de Kar, 2003). Besides these effects, CRF has
been demonstrated to participate to social interactions indirectly,
as a hypothalamic neurohormone stimulating the HPA axis(Backstrom and Winberg, 2013; Hostetler and Ryabinin, 2013)
but also directly, as an extrahypothalamic neurotransmitter pro-
moting behavioral actions (Lim et al., 2007; Sajdyk et al., 1999).
The actions of CRF are mediated by two distinct receptors: CRF1
receptor and CRF2 receptor (Chang et al., 1993). These receptors
belong to the class B subtype of G protein-coupled receptors
(GPCRs) and, like all GPCRs, consist of an amino-terminal extracel-
lular region, a carboxyl-terminal intracellular tail and seven, trans-
membrane segments, connected by alternating intracellular and
extracellular loops (Grammatopoulos et al., 2001). There is nearly
70% identity between CRF1 and CRF2 receptors at the amino acid
level with the transmembrane and intracellular domains of the
CRF receptors presenting the highest homology (over 80% identity)
(Grammatopoulos et al., 2001). A third receptor, CRF-binding pro-
tein (CRF-BP) was also isolated in the brain and the pituitary gland
and is believed to modulate the endocrine activity of CRF (Behan
et al., 1995). CRF1 and CRF2 receptors are believed to have antago-
nistic roles in the CNS. Activation of the CRF1 seemed to induce
stimulation of the HPA axis, anxiety, depression, decreased appe-
tite and increased colonic movements, inflammation
(Dautzenberg and Hauger, 2002). In contrast, activation of the
CRF2 seemed to produce anxiolytic and antidepressant effects,
decrease of food intake and gastric emptying, vasodilation,
Z. Bagosi et al. / Brain Research 1663 (2017) 114–122 115cardioprotection (Dautzenberg and Hauger, 2002). As regards the
role of CRF2 in the regulation of the HPA axis, it remains controver-
sial due to different results obtained in rats and mice (Jamieson
et al., 2006; Maruyama et al., 2007; Pelleymounter et al., 2004).
Since CRF was isolated (Vale et al., 1981), a growing family of
CRF-like peptides have been discovered. Today the mammalian
members of this family include CRF, urocortin 1 (Ucn1) (Vaughan
et al., 1995), urocortin 2 (Ucn2), also known as stresscopin-
related peptide (SRP) (Reyes et al., 2001), and urocortin 3 (Ucn3),
also known as stresscopin (Scp) (Lewis et al., 2001). The name uro-
cortin derives from the fish homologue urotensin (63% sequence
identity) and the mammalian analogue corticotropin (45%
sequence identity) (Skelton et al., 2000). These CRF-like peptides
share common amino acidic elements, but differ in their pharma-
cological properties. Thus, CRF binds preferentially to CRF1, Ucn1
attaches equipotently to both CRF receptors, whereas Ucn2 and
Ucn3 bind selectively to CRF2. In addition, CRF and Ucn1 can be
found attached to CRF-BP (Fekete and Zorrilla, 2007). Many physi-
ological functions were attributed to the urocortins, including reg-
ulation of stress response (Suda et al., 2004), modulation of food
intake and satiety (Richard et al., 2002), gastrointestinal motility
(Martinez et al., 2002), vasodilation and cardioprotection
(Takahashi et al., 2004), and recently, social interaction (Breu
et al., 2012; Deussing et al., 2010).
Previous findings regarding the possible role of CRF and CRF-
related peptides in social behavior of different species have been
reviewed in two recent studies (Backstrom and Winberg, 2013;
Hostetler and Ryabinin, 2013). Despite that the primary focus in
these studies has beenon the effects of social stressors, suchas social
defeat and social isolation on the CRF system (Backstrom and
Winberg, 2013; Carpenter et al., 2009), there have been also insights
on the role of CRF system in prosocial and affiliative behaviors, such
as parental care,maternal defense, sexual behavior andpair bonding
(Carpenter et al., 2014;Hostetler andRyabinin, 2013). The aimof our
study was to investigate the effects of the central administration of
CRF and the urocortins on the sociability of mice.2. Results
Central administration of CRF decreased significantly the num-
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Fig. 1. The effects of CRF, antalarmin and astressin2B on the number of entries in the
means ± SEM; statistically significant difference was accepted for p < 0.05 and indicatedtion (F(3,23) = 8,942; p = 0.0004) with the unknown mouse (F
(3,23) = 16.17; p < 0.0001) and the unknown object (F(3,23)
= 11.84; p < 0.0001) and consequently, the total number of entries
(F(3,23) = 18.61; p < 0.0001) and the total time of interaction (F
(3,23) = 20.21; p < 0.0001), compared to the controls (Figs. 1 and
2). The selective CRF antagonists antalarmin and astressin2B
administered alone did not alter significantly any of these param-
eters (p < 0.05) (Figs. 1 and 2). The inhibitory effects produced by
CRF were reversed by antalarmin (p < 0.05), but not astressin2B
(p > 0.05) (Figs. 3 and 4).
Central administration of Ucn1 increased significantly the num-
ber of entries into the chamber of unknown mouse (F(3,31)
= 10.24; p < 0.0001) and accordingly the total number of entries
(F(3,31) = 11.09; p < 0.0001), without influencing significantly the
number of entries into the chamber of the unknown object (F
(3,31) = 0.8287; p = 0.4882). Ucn1 did not influence the time of
interaction with the unknown male (F(3,31) = 10.74; p > 0.05)
and the unknown object (F(3,31) = 0.9611; p = 0.4234) and conse-
quently the total time of interaction was not altered either (F
(3,31) = 5.153; p = 0.0052), compared to the controls (Figs. 5 and
6). The significant effect on the number of entries and the non-
significant effect on the time of interaction induced by Ucn1 were
reduced remarkably by both antalarmin (p > 0.05) and astressin2B
(p < 0.05) (Figs. 7 and 8). Central administration of Ucn2 and
Ucn3 did not change significantly the number of entries into any
of the chambers (F(3,31) = 5.153; p = 0.0052, p > 0.05), but both
peptides reduced the time of interaction between the males
(p < 0.05). This reduction was observed only in case of the time
spent with the unknown mouse (F(3,31) = 10.74; p < 0.0001) and
the total time of interaction (F(3,31) = 11.09; p < 0.0001), but not
the time spent with the unknown object (F(3,31) = 0.9611;
p = 0.4234) (Figs. 5 and 6).
The dose-response curves indicated no significant changes in
the horizontal and the vertical activities of the mice tested in par-
allel in a conducta system, following icv injection of 0.5-1-2-
5 lg/2 ll of CRF, Ucn1, Ucn2 or Ucn3 (Figs. 9–12).3. Discussion
Based on these results, we suggest that CRF and Ucn1 may play
important, but different roles in sociability, and that Ucn2 andmpty area total entries
antalarmin (10) astressin 2B (10)
*
three chamber test investigating the sociability of mice. Values are presented as



















Fig. 2. The effects of CRF, antalarmin and astressin2B on the time of interaction in the three chamber test investigating the sociability of mice. Values are presented as
































Fig. 3. The effects of CRF, CRF with antalarmin and CRF with astressin2B on the number of entries in the three chamber test investigating the sociability of mice. Values are
presented as means ± SEM; statistically significant difference was accepted for p < 0.05 and indicated with * for CRF vs. control and # for CRF with antalarmin or astressin2B vs.
CRF.
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tions. CRF decreases sociability of male mice via CRF1, without
reducing the locomotor activity, which is consistent with its anxio-
genic effect. Ucn1 acting probably by both CRF receptors increases,
while Ucn2 and Ucn3, activating selectively CRF2, decreases the
social interaction between male mice. Thus, despite of the fact that
CRF1 and CRF2 were thought initially to play antagonistic roles in
stress response, they have been found to have contrasting, but
not necessarily opposite effects on social interaction.
Previous studies have already demonstrated that icv injection of
CRF decreased active social interaction, without a concomitant
decrease in locomotor activity, which is indicative of an anxiogenic
action for CRF (Dunn and File, 1987). In addition, infusion of CRF
and Ucn1 into the basolateral nucleus of the amygdala (BLA) pro-duced anxiogenic response in male Wistar rats, reflected by a
robust, dose-dependent decrease in social interaction times
(Sajdyk et al., 1999). The effects of both peptides were mediated
by CRF1 (Gehlert et al., 2005; Sajdyk and Gehlert, 2000). Actually,
Ucn1 was observed to be even more potent than CRF in reducing
the social interaction times, which is in agreement with their rela-
tive affinities for CRF1 (Campbell et al., 2004; Gehlert et al., 2005;
Sajdyk and Gehlert, 2000). However, the effects of UCN I in rats
seems to be site-specific: when injected into the BLA it produced
anxiety across different endocrine and behavioral markers
(Sajdyk et al., 1999); when injected into the bed nucleus of stria
terminalis (BNST), it affected only the social behavior (Lee et al.,
2008) and, when injected into the NACC, it did not alter any param-





















Fig. 4. The effects of CRF, CRF with antalarmin and CRF with astressin2B on the time of interaction in the three chamber test investigating the sociability of mice. Values are
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Fig. 5. The effects of Ucn1, Ucn2 and Ucn3 on the number of entries in the three chamber test investigating the sociability of mice. Values are presented as means ± SEM;
statistically significant difference was accepted for p < 0.05 and indicated with * for Ucn vs. control.
Z. Bagosi et al. / Brain Research 1663 (2017) 114–122 117decreased the social interaction of mice, without a concomitant
decrease of horizontal and vertical activities, which is consistent
with its anxiogenic effect that has been already indicated in rats.
Although, in our knowledge, our study is the first to demonstrate
that central administration CRF and Ucn1 have contrasting, anxio-
genic and anxiolytic actions, respectively, on the social interaction
of mice.
Previous studies also demonstrated that male, but not female
Ucn2 knock-out mice exhibited more passive social interactions
and reduced aggressiveness to novel conspecifics (Breu et al.,
2012) and that both male and female Ucn3 and CRF2 knock-
out mice, but not Ucn2 knock-out mice, expressed an enhanced
social memory and increased preference for social novelty, when
compared to wild-type mice (Deussing et al., 2010). In addition,a recent study reported that mice deficient in Ucn3 or CRF2
receptor localized specifically in the medial nucleus of the amyg-
dala (MeA) showed decreased preference for social novelty,
when compared to wild-type mice (Shemesh et al., 2016). In
contrast, pharmacological activation of the CRF2 receptors and
optogenetic activation of Ucn3 neurons in the MeA proved the
opposite, an increased preference for social novelty of mice
(Shemesh et al., 2016). Moreover, chemogenetic inhibition of
MeA Ucn3 neurons enhanced natural social behavior of the mice
without affecting their hierarchal structure. The latter finding is
concordant with our results indicating that icv administration of
both selective agonists of CRF2 decreases the social interaction of
male CFLP mice. These studies collectively suggest that Ucn3




















Fig. 6. The effects of Ucn1, Ucn2 and Ucn3 on the time of interaction in the three chamber test investigating the sociability of mice. Values are presented as means ± SEM;






























Fig. 7. The effects of Ucn1, Ucn1 with antalarmin and Ucn1 with astressin2B on the number of entries in the three chamber test investigating the sociability of mice. Values are
presented as means ± SEM; statistically significant difference was accepted for p < 0.05 and indicated with * for Ucn1 vs. control and # for Ucn1 with antalarmin or astressin2B
vs. Ucn1.
118 Z. Bagosi et al. / Brain Research 1663 (2017) 114–122mice. However, activation of CRF2 by icv administration of Ucn3
did not alter the social behavior in rats (Zhao et al., 2007).
In this order of thoughts, both CRF1 and CRF2 receptors can be
considered potential targets in the therapy of diseases in which
the sociability is typically altered, such as anxiety, depression,
schizophrenia and autism (Crawley, 2007; Takahashi, 2001;
Todorovic et al., 2005; Waters et al., 2015). However, differences
between species, strains and even sexes may also exist, which
makes the translation of the results from animals to humans diffi-
cult. Also, icv injection is a traditional method to describe the phys-
iological or pharmacological effects of peptides, but certainly, this
route of administration may prove limited, when it comes to ther-
apeutical purposes. Alternative routes of administration or addi-
tional transporters should be considered when targeting CRF
receptors in the human brain. Nevertheless, previous knock-outstudies indicate that the role of CRF1 and CRF2 receptors in
stress-related disorders is not a matter of simple dualism, but it
depends on the different brain regions and neuron populations
being activated (Janssen and Kozicz, 2013), which complicates fur-
ther the interpretation of the results described following icv
administration of CRF and CRF-like peptides. Previous studies per-
forming administration of selective CRF receptor antagonists in the
cerebral ventricle, the BNST and the dorsal raphe nucleus (DRN) of
Syrian hamsters provided evidence that CRF2, but not CRF1 recep-
tors from these regions are an important component in the neural
circuitry regulating conditioned defeat (Cooper and Huhman, 2005,
2007). In comparison, our results following icv injection of
selective CRF receptor antagonists alone did not provide any addi-
tional information regarding the role of these receptors in social
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Fig. 8. The effects of Ucn1, Ucn1 with antalarmin and Ucn1 with astressin2B on the time of interaction in the three chamber test investigating the sociability of mice. Values
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Fig. 9. The effects of CRF on the horizontal and the vertical activities of mice investigated in a conducta system. Values are presented as means ± SEM; statistically significant
difference was accepted for p < 0.05.
Z. Bagosi et al. / Brain Research 1663 (2017) 114–122 119administration of CRF receptor agonists and/or antagonists directly
into the areas involved in both stress response and social interac-
tion, such as the BLA, the MeA, the BNST, the NAcc etc. (Cooper
and Huhman, 2005, 2007; Jasnow et al., 2004; Lim et al., 2007;
Sajdyk et al., 1999; Shemesh et al., 2016).4. Materials and methods
4.1. Animals
Male CFLP mice weighing 24–30 g were used. CFLP mice, origi-
nally called CF-1 mice, belong to an outbred strain maintained by
Carworth Farms (subsequently called Anglia Laboratory Animals
Limited); stock name was changed to CFLP by Lane-Petter, but this
company later went out of business. In our experiment we used
CFLP mice because we intended to test an outbred strain, ratherthan an inbred strain, such as C57/BL6 mice, which, according to
previous studies, fail to exhibit preference for social novelty in
the three-chamber apparatus (Pearson et al., 2010). During the
experiments the mice were kept and handled in accordance with
the instructions of the University of Szeged Ethical Committee
for the Protection of Animals in Research. They were housed in
their home cages at constant room temperature (23 C) on a stan-
dard illumination schedule, with 12-h light and 12-h dark periods
(lights on from 6:00 a.m.). Commercial food and tap water were
available ad libitum. The mice were handled daily to minimize
the effects of nonspecific stress.4.2. Surgery
The mice were implanted with a stainless steel Luer cannula
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Fig. 10. The effects of Ucn1 on the horizontal and the vertical activities of mice investigated in a conducta system. Values are presented as means ± SEM; statistically
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Fig. 11. The effects of Ucn2 on the horizontal and the vertical activities of mice investigated in a conducta system. Values are presented as means ± SEM; statistically
significant difference was accepted for p < 0.05.
120 Z. Bagosi et al. / Brain Research 1663 (2017) 114–122anesthesia with 60 mg/kg Euthanasol (CEVA-Phylaxia, Hungary).
Cannulas were secured to the skull with dental cement and acry-
late. The stereotaxic coordinates were 0.5 mm posterior and
0.5 mm lateral to the bregma, and 3 mm deep from the dural sur-
face. The mice were allowed for 5 days to recover after the surgery
and the permeability of the canulla was tested with methylene-
blue after the experiments.4.3. Treatment
Four experiments were performed with four different groups. In
the first experiment, group 1 was treated with saline solution,
group 2 with CRF, group 3 with antalarmin and group 4 with
astressin2B. In the second experiment, group 1 was treated withsaline and the remaining groups were treated with CRF alone or
in combination with antalarmin or astressin2B. In the third exper-
iment, group 1 was treated with saline and the second, the third
and the fourth group with Ucn1, Ucn2 and Ucn3, respectively. In
the fourth experiment, the first group was treated with saline,
the remaining groups were treated with Ucn1 alone or in combina-
tion with antalarmin or astressin2B. In case of the single adminis-
tration, the injection of the agonist or the antagonist was
performed 30 min before the social interaction test, whereas in
case of the combined administration, injection of the antagonist
was performed 30 min before that of the agonist, which means
60 min before the test itself. Saline (0.9% NaCl) solution (Biogal,
Hungary) was used as vehicle for both agonist and antagonist



























8 8 8 8 8 8 8 8 8 8 
Fig. 12. The effects of Ucn3 on the horizontal and the vertical activities of mice investigated in a conducta system. Values are presented as means ± SEM; statistically
significant difference was accepted for p < 0.05.
Z. Bagosi et al. / Brain Research 1663 (2017) 114–122 121Switzerland) was 5 lg/2 ll, which proved effective in producing a
corticosterone response in our previous experiments (Bagosi et al.,
2013, 2014). The doses of antalarmin (Sigma Aldrich Inc., USA) and
astressin2B (Sigma Aldrich Inc., USA) were 0.1 lg/2 ll and
1 lg/2 ll, which proved to abolish this response (Bagosi et al.,
2014). In addition, these antagonists have been already shown to
effectively block the freezing action induced by CRF, without alter-
ing the baseline social interaction (Bhutada et al., 2010; Zorrilla
et al., 2013).4.4. Social interaction test
Thirty minutes after ICV injection of the peptides mice were
investigated in a social interaction test arena invented by Crawley
and colleagues (Crawley, 2007). The apparatus was a rectangular,
three-chamber box. Each chamber of 19  45  25 cm and were
made from clear Plexiglas, with an open middle section, which
allowed free access to each chamber. The right and left chambers
could be isolated from the middle one by using two dividing Plex-
iglass walls. Two identical, wire cup-like cage of 10  17 cm with
removable lids that large enough to hold a single mouse were
placed vertically inside the apparatus, one in each side chamber.
Each cage was comprised of metal wires to allow for air exchange
between the interior and exterior of the cylinder but small enough
to prevent direct physical interactions between an animal on the
inside with one on the outside. In the our experiments an unknown
mouse (a male set in a cage) was put in the first chamber and an
unknown object (an empty cage) was put in the opposite chamber.
First the tested mouse was habituated with the middle chamber
for 5 min and then allowed to explore the remaining chambers
for another 5 min, during which the number of entries and the
time of interaction were measured. The mouse was considered to
be in the chamber when its head and four paws have entered into
the chamber. The time of interaction was represented by the time
spent in an area 3–5 cm around the cage with stretching, grooming
and licking of the body of the other mouse or the grids. Behavioral
testing were performed between 9:00 a.m. and 13:00 p.m. General
room lighting was 650 lux. The person who made the observation
was at 2 meters away from the apparatus. After each trial, all
chambers were cleaned with 70% ethanol and then with Clidox1:5:1 to prevent olfactory cue bias and to ensure proper disinfec-
tion, respectively (Kaidanovich-Beilin et al., 2011).
4.5. Open-field test
In parallel with the social interaction test, the horizontal loco-
motor activity and the vertical locomotor activity of the mice were
monitored in an in vivo conducta system, based on the principles of
an open-field test (Conducta 1.0, Experimetria Ltd., Budapest, Hun-
gary). The conducta apparatus was a square open-field black cage
with a side length of 60 cm, surrounded by a 40 cm high wall.
The floor of the cage was divided in 36 (6  6) small squares. Five
by five rows of photocell beams allowed a computer-based system
to register the behavioral activity of each animal. A 60 W light was
situated 1 m above the arena floor. Each tested mouse was placed
in the center of the open field for 5 min for habituation and then
monitored for 30 min during free exploration. The box was cleaned
between sessions with 96% ethyl-alcohol (Reanal Ltd., Hungary).
4.6. Statistical analysis
Statistical analysis of the results was performed by analysis of
variance (ANOVA, GraphPad Prism Software). The differences
between groups were tested by one-way ANOVA followed by
Tukey post-hoc comparison test for the social interaction test or
Dunnett post-hoc comparison test for the open-field test. A proba-
bility level of 0.05 or less was accepted as indicating a statistically
significant difference.
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